Cargando…
Circulating PCSK9 Level and Risk of Cardiovascular Events and Death in Hemodialysis Patients
Proprotein convertase subtilisin/kexin type 9 (PCSK9) is a promising new target for the prevention of cardiovascular (CV) events. However, the clinical significance of circulating PCSK9 is unclear in hemodialysis (HD) patients. A total of 353 HD patients were prospectively enrolled from June 2016 to...
Autores principales: | Hwang, Hyeon Seok, Kim, Jin Sug, Kim, Yang Gyun, Lee, So-Young, Ahn, Shin Young, Lee, Hong Joo, Lee, Dong-Young, Lee, Sang Ho, Moon, Ju Young, Jeong, Kyung Hwan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019341/ https://www.ncbi.nlm.nih.gov/pubmed/31963408 http://dx.doi.org/10.3390/jcm9010244 |
Ejemplares similares
-
Circulating Neprilysin Level Predicts the Risk of Cardiovascular Events in Hemodialysis Patients
por: Hwang, Hyeon Seok, et al.
Publicado: (2021) -
Circulating Vascular Adhesion Protein-1 Level Predicts the Risk of Cardiovascular Events and Mortality in Hemodialysis Patients
por: Kim, Dae Kyu, et al.
Publicado: (2021) -
Clinical implications of circulating follistatin-like protein-1 in hemodialysis patients
por: Kim, Dae Kyu, et al.
Publicado: (2023) -
Gait speed and handgrip strength as predictors of all-cause mortality and cardiovascular events in hemodialysis patients
por: Lee, Yu Ho, et al.
Publicado: (2020) -
Plasma Endocan as a Predictor of Cardiovascular Event in Patients with End-Stage Renal Disease on Hemodialysis
por: Kim, Jin Sug, et al.
Publicado: (2020)